Currently out of the existing stock ratings of Christyan Malek, 29 are a SELL (23.58%), 70 are a BUY (56.91%), 24 are a HOLD (19.51%).

Christyan Malek

Work Performance Price Targets & Ratings Chart

Analyst Christyan Malek, currently employed at JPMORGAN, carries an average stock price target met ratio of 43.08% that have a potential upside of 22.38% achieved within 190 days.

Christyan Malek’s has documented 234 price targets and ratings displayed on 9 stocks. The coverage is on the Energy sector.

Most recent stock forecast was given on EQNR, Equinor ASA ADR at 08-Dec-2023.

Wall Street Analyst Christyan Malek

Analyst best performing recommendations are on EQNR (EQUINOR ASA ADR).
The best stock recommendation documented was for EQNR (EQUINOR ASA ADR) at 3/10/2022. The price target of $31.76 was fulfilled within 29 days with a profit of $4.56 (16.76%) receiving and performance score of 5.78.

Average potential price target upside

BP BP PLC ADR E Eni SpA ADR EQNR Equinor ASA ADR GLPEY Galp Energa OM Outset Medical  REPYY Repsol SA TTE TotalEnergies SE ADR OMVKY OMV AG PK SHEL Shell PLC ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$33

$3.92 (13.48%)

$35

19 days ago
(30-Oct-2024)

8/16 (50%)

$3.98 (13.71%)

128

Buy

$36

$6.92 (23.80%)

$42

1 months 8 days ago
(10-Oct-2024)

3/8 (37.5%)

$3.66 (11.32%)

181

Buy

$7.84

3 months 11 days ago
(07-Aug-2024)

0/7 (0%)

$-28.24 (-78.27%)

Hold

$40

$10.92 (37.55%)

$43

4 months 1 days ago
(17-Jul-2024)

6/13 (46.15%)

$4.58 (12.93%)

525

Buy

$41.5

$12.42 (42.71%)

$7.38

4 months 3 days ago
(15-Jul-2024)

0/15 (0%)

$6.47 (18.47%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Christyan Malek?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?